OptimizeRx (OPRX) Income from Non-Controlling Interests (2021 - 2023)
OptimizeRx (OPRX) reported Income from Non-Controlling Interests of -$4.2 million for Q2 2023, down 7.12% on a YoY basis from -$4.5 million in Q2 2022, and up 34.95% sequentially from -$6.4 million in Q1 2023.
OptimizeRx (OPRX) Income from Non-Controlling Interests (2021 - 2023) Analysis & Trends
OptimizeRx (OPRX) has 3 years of Income from Non-Controlling Interests data on file, last reported at -$4.2 million in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 32.11 Bn | 24.79 Bn | 662.02 Mn | - |
| 2 | BrightSpring Health Services | 14.63 Bn | 13.73 Bn | 482.22 Mn | -157,000.00 |
| 3 | Healthequity | 8.29 Bn | 8.02 Bn | 256.31 Mn | - |
| 4 | Hinge Health | 5.96 Bn | 5.65 Bn | 154.23 Mn | - |
| 5 | 10x Genomics | 5.92 Bn | 5.38 Bn | 106.18 Mn | - |
| 6 | MiniMed | 4.53 Bn | 4.23 Bn | 480.00 Mn | - |
| 7 | Waystar Holding | 4.46 Bn | 4.40 Bn | 216.84 Mn | - |
| 8 | Doximity | 3.96 Bn | 3.21 Bn | 125.97 Mn | - |
| 9 | Privia Health | 3.14 Bn | 2.72 Bn | - | 646,000.00 |
| 10 | OptimizeRx | 119.70 Mn | 99.53 Mn | 14.93 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -4.16 Mn |
| Mar 31, 2023 | -6.40 Mn |
| Sep 30, 2022 | -3.47 Mn |
| Jun 30, 2022 | -3.88 Mn |
| Mar 31, 2022 | -3.76 Mn |
| Sep 30, 2021 | 39,894.00 |
| Jun 30, 2021 | 352,100.00 |